Showing results (81-90 of 168) with videos related to
Sort By:
Pageof 17
Pharmacotherapy|September 26, 2015
Atomoxetine for Orthostatic Hypotension in an Elderly Patient Over 10 Weeks: A Case ReportGenevieve M Hale, Michael BrennerJournal of Child Neurology|October 24, 2003
Alexander's disease: clinical, pathologic, and genetic featuresAnne B Johnson, Michael BrennerNature Communications|May 17, 2018
Tissue and cellular rigidity and mechanosensitive signaling activation in Alexander diseaseLiqun Wang, Jing Xia, Jonathan Li, et al.Journal of Neuroimmunology|June 12, 2003
Experimental autoimmune encephalomyelitis relapses are reduced in heterozygous golli MBP knockout miceRhonda R Voskuhl, Thomas M Pribyl, Kathy Kampf, et al.Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
The Effects of Ranolazine on Hemoglobin A1c in a Veteran PopulationLindsey Greiner, Kathryn Hurren, Michael BrennerThe Annals of Pharmacotherapy|February 27, 2016
Ranolazine and Its Effects on Hemoglobin A1CLindsey Greiner, Kathryn Hurren, Michael BrennerAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 4, 2015
Managing comorbidities in patients with chronic heart failure: first, do no harmBeth DeJongh, Kade Birkeland, Michael BrennerAnnals of Neurology|February 26, 2005
Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander diseaseRong Li, Anne B Johnson, Gajja Salomons, et al.Annals of the New York Academy of Sciences|April 24, 2004
Severity of neurodegeneration correlates with compromise of iron metabolism in mice with iron regulatory protein deficienciesSophia R Smith, Sharon Cooperman, Tim Lavaute, et al.The Annals of Pharmacotherapy|January 18, 2017
The Treatment of Primary Orthostatic HypotensionGenevieve M Hale, Jose Valdes, Michael BrennerPageof 17